Newsroom
Newsroom
-
2022 Future Healthcare 100 - Top 100 Innovative Biomedicine Companies
2022-06-16Shenzhen INNORNA Biotechnology Co., Ltd won the honor of “Top 100 Innovative Biomedicine Companies” on the 2022 Future Healthcare 100 list on June 15.Learn More + -
China Healthcare Consulting
2022-05-26TOP15 Best New and Rising Healthcare Companies 2021Learn More + -
INNORNA: Explore Frontier of mRNA Application Based on Platform Technology
2022-03-28Our company officially announced the completion of 120 million US dollars in Series B funding in March 2022, totaling the size of our equity financing to more than one billion RMB since the establishment of the company. Currently, the company has applied for multiple technology patents with importanLearn More + -
INNORNA raises USD 120 million in Series B funding
2022-03-28Shenzhen, March 28, 2022 - Shenzhen INNORNA Biotechnology Co., Ltd. (hereinafter referred to as “INNORNA”) officially announced that it has raised USD 120 million in Series B funding. CDH Investment and HHF Capital were the lead-investors and E Fund Capital and Blue Ocean Capital Group were co-invLearn More + -
Shenzhen Bay International Innovation Alliance
2022-01-10TOP 100 New Economy Companies in GBA 2021Learn More + -
MedClub
2021-10-11TOP 50 Innovative Biotech companies in China 2021Learn More + -
MENET
2021-09-26TOP 30 Innovative Pharmaceutical Companies in China 2020Learn More + -
CB Insights
2021-07-309 Influential RNA companies in China 2021Learn More +